Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN||1821281 / 1||LA / IM|
Administered by: Pharmacy Purchased by: ??
Symptoms: Angiogram pulmonary abnormal, Arthralgia, Atelectasis, C-reactive protein increased, Chest pain, Discomfort, Dyspnoea, Echocardiogram, Electrocardiogram abnormal, Lung consolidation, Myalgia, Pericarditis, Pleuritic pain, Supraventricular tachycardia, Red blood cell sedimentation rate increased, Diastolic dysfunction, Cardiac monitoring, Troponin increased, Ejection fraction normal, N-terminal prohormone brain natriuretic peptide increased, Atrial enlargement, Lung opacity
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days: 2
Write-up: Developed myalgias and joint pains approximately 48 hours after the injection, then improved. Then about a week after the injection, developed severe myalgias and joint pains. Treated with Medrol dose pack (6 days) with improvement. 3 days later developed pleuritic chest pain as well as shortness of breath. Presented 48 hours after this started for medical care and was diagnosed with acute pericarditis. Started on ibuprofen 600 mg TID and colchicine 0.6 mg BID with significant improvement in discomfort. Discharged from the hospital after 48 hours of observation. Did develop paroxysmal SVT which was felt to be 2/2 to the acute pericarditis. Started on metoprolol tartrate 50 mg BID to help with rate control and sent home with zio patch for additional cardiac monitoring.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166